EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Novel Anti-MRSA Peptide from Mangrove-Derived Virgibacillus chiguensis FN33 Supported by Genomics and Molecular Dynamics

Namfa Sermkaew iD, Apichart Atipairin iD, Phetcharat Boonruamkaew iD, Sucheewin Krobthong iD, Chanat Aonbangkhen iD, Jumpei Uchiyama iD, Yodying Yingchutrakul iD, Nuttapon Songnaka iD

Marine Drugs · 14.05.2025 · 23 (5) · 209

DOI: 10.3390/md23050209 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Marine Drugs, online erschienen am 14.05.2025. Verfasst von Namfa Sermkaew und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Walailak University, Thasala, Nakhon Si Thammarat 80160, Thailand. Hauptthemen laut MEDLINE: Methicillin-Resistant Staphylococcus aureus, Anti-Bacterial Agents, Virgibacillus, Antimicrobial Peptides. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 99 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Walailak University annual government statement of expenditure under the Plant Genetic Conservation Project Under The Royal Initiative of Her Royal Highness Pr….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antimicrobial resistance (AMR) is a global health threat, with methicillin-resistant Staphylococcus aureus (MRSA) being one of the major resistant pathogens. This study reports the isolation of a novel mangrove-derived bacterium, Virgibacillus chiguensis FN33, as identified through genome analysis and the discovery of a new anionic antimicrobial peptide (AMP) exhibiting anti-MRSA activity. The AMP was composed of 23 amino acids, which were elucidated as NH3-Glu-Gly-Gly-Cys-Gly-Val-Asp-Thr-Trp-Gly-Cys-Leu-Thr-Pro-Cys-His-Cys-Asp-Leu-Phe-Cys-Thr-Thr-COOH. The minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) for MRSA were 8 µg/mL and 16 µg/mL, respectively. FN33 AMP induced cell membrane permeabilization, suggesting a membrane-disrupting mechanism. The AMP remained stable at 30–40 °C but lost activity at higher temperatures and following exposure to proteases, surfactants, and extreme pH. All-atom molecular dynamics simulations showed that the AMP adopts a β-sheet structure upon membrane interaction. These findings suggest that Virgibacillus chiguensis FN33 is a promising source of novel antibacterial agents against MRSA, supporting alternative strategies for drug-resistant infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Methicillin-Resistant Staphylococcus aureusAnti-Bacterial AgentsVirgibacillusAntimicrobial PeptidesMolecular Dynamics SimulationMicrobial Sensitivity TestsGenomics

Stichwörter der Autor:innen

AMPFN33MRSAVirgibacillus chiguensisanionic AMPantimicrobial peptideantimicrobial resistancegenomemolecular dynamics simulations

Substanzen

Anti-Bacterial AgentsAntimicrobial Peptides

Autor:innen und Institutionen

  • School of Pharmacy, Walailak University, Thasala, Nakhon Si Thammarat 80160, Thailand.
  • Drug and Cosmetics Excellence Center, Walailak University, Thasala, Nakhon Si Thammarat 80160, Thailand.
  • Center of Excellence in Natural Products Chemistry (CENP), Department of Chemistry, Faculty of Science, Chulalongkorn University, Bangkok 10330, Thailand.
  • Center of Excellence on Petrochemical and Materials Technology, Chulalongkorn University, Bangkok 10330, Thailand.
  • Department of Bacteriology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama 700-8558, Japan.
  • National Center for Genetic Engineering and Biotechnology, National Science and Technology Development Agency, Pathum Thani 12120, Thailand.

ORCID-Profile: Namfa Sermkaew, Apichart Atipairin, Phetcharat Boonruamkaew, Sucheewin Krobthong, Chanat Aonbangkhen, Jumpei Uchiyama, Yodying Yingchutrakul, Nuttapon Songnaka

Förderung

  • Walailak University annual government statement of expenditure under the Plant Genetic Conservation Project Under The Royal Initiative of Her Royal Highness Pr…

Zitieren

APA

Sermkaew, N., Atipairin, A., Boonruamkaew, P., Krobthong, S., Aonbangkhen, C., Uchiyama, J., Yingchutrakul, Y., & Songnaka, N. (2025). Novel Anti-MRSA Peptide from Mangrove-Derived Virgibacillus chiguensis FN33 Supported by Genomics and Molecular Dynamics. Marine Drugs, 23(5), 209. https://doi.org/10.3390/md23050209

Vancouver

Sermkaew N, Atipairin A, Boonruamkaew P, Krobthong S, Aonbangkhen C, Uchiyama J, et al. Novel Anti-MRSA Peptide from Mangrove-Derived Virgibacillus chiguensis FN33 Supported by Genomics and Molecular Dynamics. Marine Drugs. 2025;23(5):209. doi:10.3390/md23050209

BibTeX
@article{Sermkaew2025,
  author = {Sermkaew, Namfa and Atipairin, Apichart and Boonruamkaew, Phetcharat and Krobthong, Sucheewin and Aonbangkhen, Chanat and Uchiyama, Jumpei and Yingchutrakul, Yodying and Songnaka, Nuttapon},
  title = {Novel Anti-MRSA Peptide from Mangrove-Derived Virgibacillus chiguensis FN33 Supported by Genomics and Molecular Dynamics},
  journal = {Marine Drugs},
  year = {2025},
  volume = {23},
  number = {5},
  pages = {209},
  doi = {10.3390/md23050209}
}
Kostenlos starten →